FCH
TMO icon

Freestone Capital Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Freestone Capital Holdings’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$5.31M – 467
2023
Q4 		$5.31M Hold
10,000
– – 0.24% 72
2023
Q3 		$5.06M Hold
10,000
– – 0.27% 66
2023
Q2 		$5.22M Hold
10,000
– – 0.21% 71
2023
Q1 		$5.76M Hold
10,000
– – 0.26% 62
2022
Q4 		$5.51M Buy
+10,000
New +$5.3M 0.25% 65

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Freestone Capital Holdings's TMO Position: Q2 2026 in Review

Freestone Capital Holdings reduced its Thermo Fisher Scientific (TMO) stake by 32% in Q2 2026, selling an estimated $4.64M and leaving 20,141 shares worth $10.1M. The position accounts for 0.26% of the portfolio, ranked #64.

Freestone Capital Holdings first reported a position in TMO in Q2 2013 and has held it in 41 quarters since. The position peaked at $17.5M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Freestone Capital Holdings held 20,141 shares of Thermo Fisher Scientific worth $10.1M as of Q2 2026.
  • Freestone Capital Holdings sold 9,669 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.64M.
  • Thermo Fisher Scientific made up 0.26% of Freestone Capital Holdings's portfolio in Q2 2026, its #64 holding.
  • Freestone Capital Holdings first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 41 quarters since.
  • Freestone Capital Holdings's Thermo Fisher Scientific position peaked at $17.5M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.